Study of cyclooxygenase-2 in renal cell carcinoma. 2004

Rikio Yoshimura, and Masahide Matsuyama, and Yutaka Kawahito, and Kenji Tsuchida, and Katsuyuki Kuratsukuri, and Yoshiaki Takemoto, and Makoto Mitsuhashi, and Hajime Sano, and Tatsuya Nakatani
Department of Urology, Osaka City University Hospital, Abenoku, Osaka 545-8585, Japan. jasmin@med.osaka-cu.ac.jp

Cyclooxygenase (COX)-2 plays an important role in the development of various cancers due to its angiogenetic function. As the expression of COX-2 is up-regulated in human colorectal carcinoma and other cancers, we investigated the expression of COX-2 in human renal cell carcinoma (RCC) tissues. One hundred and eight specimens were obtained from patients with RCC, and 20 from normal kidney (NK) tissues. Immunohistochemistry, using affinity purified anti-bodies against human COX-2, and RT-PCR to study the COX-2 mRNA expression were carried out. We also examined whether or not there was a significant difference in the expression of COX-2 among grades (G1, G2, G3) and stages (pT1, pT2, pT3a, pT3b) in RCC. While no marked expression of COX-2 was observed in the NK tissues, a significantly strong expression of COX-2 was detected in RCC tissues. The extent and intensity of immunoreactive COX-2 polypeptides in cancer cells were statistically greater than those of cells from normal kidney tissues. However, no marked difference was seen among grades or between stages. These results demonstrate that the generated COX-2 in human renal cell carcinoma plays an important role in the proliferation of malignant renal cells.

UI MeSH Term Description Entries
D007150 Immunohistochemistry Histochemical localization of immunoreactive substances using labeled antibodies as reagents. Immunocytochemistry,Immunogold Techniques,Immunogold-Silver Techniques,Immunohistocytochemistry,Immunolabeling Techniques,Immunogold Technics,Immunogold-Silver Technics,Immunolabeling Technics,Immunogold Silver Technics,Immunogold Silver Techniques,Immunogold Technic,Immunogold Technique,Immunogold-Silver Technic,Immunogold-Silver Technique,Immunolabeling Technic,Immunolabeling Technique,Technic, Immunogold,Technic, Immunogold-Silver,Technic, Immunolabeling,Technics, Immunogold,Technics, Immunogold-Silver,Technics, Immunolabeling,Technique, Immunogold,Technique, Immunogold-Silver,Technique, Immunolabeling,Techniques, Immunogold,Techniques, Immunogold-Silver,Techniques, Immunolabeling
D007527 Isoenzymes Structurally related forms of an enzyme. Each isoenzyme has the same mechanism and classification, but differs in its chemical, physical, or immunological characteristics. Alloenzyme,Allozyme,Isoenzyme,Isozyme,Isozymes,Alloenzymes,Allozymes
D008297 Male Males
D008565 Membrane Proteins Proteins which are found in membranes including cellular and intracellular membranes. They consist of two types, peripheral and integral proteins. They include most membrane-associated enzymes, antigenic proteins, transport proteins, and drug, hormone, and lectin receptors. Cell Membrane Protein,Cell Membrane Proteins,Cell Surface Protein,Cell Surface Proteins,Integral Membrane Proteins,Membrane-Associated Protein,Surface Protein,Surface Proteins,Integral Membrane Protein,Membrane Protein,Membrane-Associated Proteins,Membrane Associated Protein,Membrane Associated Proteins,Membrane Protein, Cell,Membrane Protein, Integral,Membrane Proteins, Integral,Protein, Cell Membrane,Protein, Cell Surface,Protein, Integral Membrane,Protein, Membrane,Protein, Membrane-Associated,Protein, Surface,Proteins, Cell Membrane,Proteins, Cell Surface,Proteins, Integral Membrane,Proteins, Membrane,Proteins, Membrane-Associated,Proteins, Surface,Surface Protein, Cell
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011451 Prostaglandin-Endoperoxide Synthases Enzyme complexes that catalyze the formation of PROSTAGLANDINS from the appropriate unsaturated FATTY ACIDS, molecular OXYGEN, and a reduced acceptor. Fatty Acid Cyclo-Oxygenase,PGH Synthase,Prostaglandin H Synthase,Prostaglandin Synthase,Prostaglandin-Endoperoxide Synthase,Arachidonic Acid Cyclooxygenase,Cyclo-Oxygenase,Cyclooxygenase,Cyclooxygenases,Hydroperoxide Cyclase,PGH2 Synthetase,Prostaglandin Cyclo-Oxygenase,Prostaglandin Cyclooxygenase,Prostaglandin Endoperoxide Synthetase,Prostaglandin G-H Synthase,Prostaglandin H2 Synthetase,Prostaglandin Synthetase,Cyclase, Hydroperoxide,Cyclo Oxygenase,Cyclo-Oxygenase, Fatty Acid,Cyclo-Oxygenase, Prostaglandin,Cyclooxygenase, Arachidonic Acid,Cyclooxygenase, Prostaglandin,Endoperoxide Synthetase, Prostaglandin,Fatty Acid Cyclo Oxygenase,G-H Synthase, Prostaglandin,Prostaglandin Cyclo Oxygenase,Prostaglandin Endoperoxide Synthases,Prostaglandin G H Synthase,Synthase, PGH,Synthase, Prostaglandin,Synthase, Prostaglandin G-H,Synthase, Prostaglandin H,Synthase, Prostaglandin-Endoperoxide,Synthases, Prostaglandin-Endoperoxide,Synthetase, PGH2,Synthetase, Prostaglandin,Synthetase, Prostaglandin Endoperoxide,Synthetase, Prostaglandin H2
D002292 Carcinoma, Renal Cell A heterogeneous group of sporadic or hereditary carcinoma derived from cells of the KIDNEYS. There are several subtypes including the clear cells, the papillary, the chromophobe, the collecting duct, the spindle cells (sarcomatoid), or mixed cell-type carcinoma. Adenocarcinoma, Renal Cell,Carcinoma, Hypernephroid,Grawitz Tumor,Hypernephroma,Renal Carcinoma,Adenocarcinoma Of Kidney,Adenocarcinoma, Renal,Chromophil Renal Cell Carcinoma,Chromophobe Renal Cell Carcinoma,Clear Cell Renal Carcinoma,Clear Cell Renal Cell Carcinoma,Collecting Duct Carcinoma,Collecting Duct Carcinoma (Kidney),Collecting Duct Carcinoma of the Kidney,Nephroid Carcinoma,Papillary Renal Cell Carcinoma,Renal Cell Cancer,Renal Cell Carcinoma,Renal Cell Carcinoma, Papillary,Renal Collecting Duct Carcinoma,Sarcomatoid Renal Cell Carcinoma,Adenocarcinoma Of Kidneys,Adenocarcinomas, Renal Cell,Cancer, Renal Cell,Carcinoma, Collecting Duct,Carcinoma, Collecting Duct (Kidney),Carcinoma, Nephroid,Carcinoma, Renal,Carcinomas, Collecting Duct,Carcinomas, Collecting Duct (Kidney),Carcinomas, Renal Cell,Collecting Duct Carcinomas,Collecting Duct Carcinomas (Kidney),Hypernephroid Carcinoma,Hypernephroid Carcinomas,Hypernephromas,Kidney, Adenocarcinoma Of,Nephroid Carcinomas,Renal Adenocarcinoma,Renal Adenocarcinomas,Renal Carcinomas,Renal Cell Adenocarcinoma,Renal Cell Adenocarcinomas,Renal Cell Cancers,Renal Cell Carcinomas,Tumor, Grawitz
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

Rikio Yoshimura, and Masahide Matsuyama, and Yutaka Kawahito, and Kenji Tsuchida, and Katsuyuki Kuratsukuri, and Yoshiaki Takemoto, and Makoto Mitsuhashi, and Hajime Sano, and Tatsuya Nakatani
December 2018, The Malaysian journal of pathology,
Rikio Yoshimura, and Masahide Matsuyama, and Yutaka Kawahito, and Kenji Tsuchida, and Katsuyuki Kuratsukuri, and Yoshiaki Takemoto, and Makoto Mitsuhashi, and Hajime Sano, and Tatsuya Nakatani
January 2001, Veterinary pathology,
Rikio Yoshimura, and Masahide Matsuyama, and Yutaka Kawahito, and Kenji Tsuchida, and Katsuyuki Kuratsukuri, and Yoshiaki Takemoto, and Makoto Mitsuhashi, and Hajime Sano, and Tatsuya Nakatani
October 2014, Anticancer research,
Rikio Yoshimura, and Masahide Matsuyama, and Yutaka Kawahito, and Kenji Tsuchida, and Katsuyuki Kuratsukuri, and Yoshiaki Takemoto, and Makoto Mitsuhashi, and Hajime Sano, and Tatsuya Nakatani
June 2012, Korean journal of pathology,
Rikio Yoshimura, and Masahide Matsuyama, and Yutaka Kawahito, and Kenji Tsuchida, and Katsuyuki Kuratsukuri, and Yoshiaki Takemoto, and Makoto Mitsuhashi, and Hajime Sano, and Tatsuya Nakatani
February 2005, Yonsei medical journal,
Rikio Yoshimura, and Masahide Matsuyama, and Yutaka Kawahito, and Kenji Tsuchida, and Katsuyuki Kuratsukuri, and Yoshiaki Takemoto, and Makoto Mitsuhashi, and Hajime Sano, and Tatsuya Nakatani
April 2004, Histopathology,
Rikio Yoshimura, and Masahide Matsuyama, and Yutaka Kawahito, and Kenji Tsuchida, and Katsuyuki Kuratsukuri, and Yoshiaki Takemoto, and Makoto Mitsuhashi, and Hajime Sano, and Tatsuya Nakatani
January 2004, International journal of immunopathology and pharmacology,
Rikio Yoshimura, and Masahide Matsuyama, and Yutaka Kawahito, and Kenji Tsuchida, and Katsuyuki Kuratsukuri, and Yoshiaki Takemoto, and Makoto Mitsuhashi, and Hajime Sano, and Tatsuya Nakatani
January 2005, Journal of cutaneous pathology,
Rikio Yoshimura, and Masahide Matsuyama, and Yutaka Kawahito, and Kenji Tsuchida, and Katsuyuki Kuratsukuri, and Yoshiaki Takemoto, and Makoto Mitsuhashi, and Hajime Sano, and Tatsuya Nakatani
August 2019, Oncology letters,
Rikio Yoshimura, and Masahide Matsuyama, and Yutaka Kawahito, and Kenji Tsuchida, and Katsuyuki Kuratsukuri, and Yoshiaki Takemoto, and Makoto Mitsuhashi, and Hajime Sano, and Tatsuya Nakatani
December 2004, The Journal of urology,
Copied contents to your clipboard!